<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hartono</style></author><author><style face="normal" font="default" size="100%">B Suryawati</style></author><author><style face="normal" font="default" size="100%">Y Sari</style></author><author><style face="normal" font="default" size="100%">A Avicena</style></author><author><style face="normal" font="default" size="100%">Maryani</style></author><author><style face="normal" font="default" size="100%">C Sukmagautama</style></author><author><style face="normal" font="default" size="100%">H Apriningsih</style></author><author><style face="normal" font="default" size="100%">L Shofiyah</style></author><author><style face="normal" font="default" size="100%">RGH Novika</style></author><author><style face="normal" font="default" size="100%">NJ Wahidah</style></author><author><style face="normal" font="default" size="100%">NY Rahmawati</style></author><author><style face="normal" font="default" size="100%">ANM Ansori</style></author><author><style face="normal" font="default" size="100%">L Sumarno</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Effect of Curcumin and Virgin Coconut Oil Towards Cytokines Levels in COVID-19 Patients at Universitas Sebelas Maret Hospital, Surakarta, Indonesia</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">216-225</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; To date, no specific therapeutic drug has been approved to target SARS-CoV-2. Hence, it remains a major challenge to decide what potential therapeutic regimens to treat COVID-19 patients. This study aims to investigate curcumin and virgin coconut oil (VCO) effects on cytokine levels (IL-1β, IL-2, IL-6, IL-18, TNF-α, and IFN-β) in COVID-19 patients. &lt;strong&gt;Methods&lt;/strong&gt;: This study was a single-center, controlled trial with a parallel Arm or a Randomized Clinical trial design. A total of sixty COVID-19 patients admitted to the Universitas Sebelas Maret Hospital, Surakarta, Indonesia, were divided into two groups. The first group, consisting of 30 patients, was treated with Azithromycin 500 mg + Oseltamivir 2×75 mg + Hydroxychloroquine 400 mg/day for 5 days. The second group, comprising 30 patients, was treated with Azithromycin 500 mg + Oseltamivir 2×75 mg + Hydroxychloroquine 400 mg/day for 5 days, added with VCO 30 mL and curcumin 3×1 g/day for 21 days. The cytokine profiles of the serum samples were analyzed by the enzyme-linked immunosorbent assay (ELISA) on days 1, 14, and 21. &lt;strong&gt;Results:&lt;/strong&gt; Our study showed that the second group had a significant reduction in IL-1β, IL-2, IL-6, TNF-α, and IFN-β levels after being treated with standard therapy added with curcumin and VCO on day 21 (p&amp;lt;0.05).&lt;strong&gt; Conclusion:&lt;/strong&gt; These results suggested that curcumin and VCO might benefit the treatment of COVID-19 patients.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Key words:&lt;/strong&gt; COVID-19, Curcumin, Cytokines, Virgin coconut oil.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">216</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Hartono&lt;sup&gt;1,2*&lt;/sup&gt;, B Suryawati&lt;sup&gt;3&lt;/sup&gt;, Y Sari&lt;sup&gt;4&lt;/sup&gt;, A Avicena&lt;sup&gt;2&lt;/sup&gt;, Maryani&lt;sup&gt;3&lt;/sup&gt;, C Sukmagautama&lt;sup&gt;2&lt;/sup&gt;, H Apriningsih&lt;sup&gt;2&lt;/sup&gt;, L Shofiyah&lt;sup&gt;2&lt;/sup&gt;, RGH Novika&lt;sup&gt;5&lt;/sup&gt;, NJ Wahidah&lt;sup&gt;5&lt;/sup&gt;, NY Rahmawati&lt;sup&gt;6&lt;/sup&gt;, ANM Ansori&lt;sup&gt;7&lt;/sup&gt;, L Sumarno&lt;sup&gt;8&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Physiology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Universitas Sebelas Maret (UNS) Teaching Hospital, Surakarta, Indonesia&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Microbiology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Parasitology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Midwifery Study Program, Faculty of Medicine, Universitas Sebelas Maret, Indonesia&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Doctoral Program of Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;8&lt;/sup&gt;National Research and Innovation Agency, Jakarta, Indonesia&lt;/p&gt;
</style></auth-address></record></records></xml>